Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel

This study assessed the effect of efavirenz mid-dose plasma concentrations on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among 49 HIV infected women coadministering ethinylestradiol/levonorgestrel, including 34 HIV positive women on Highly Active Antiretroviral Ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Grant Munkwase, Kuteesa R. Bisaso, Othman Kakaire, Sarah Nanzigu
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:AIDS Research and Treatment
Online Access:http://dx.doi.org/10.1155/2017/6531709
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554302089986048
author Grant Munkwase
Kuteesa R. Bisaso
Othman Kakaire
Sarah Nanzigu
author_facet Grant Munkwase
Kuteesa R. Bisaso
Othman Kakaire
Sarah Nanzigu
author_sort Grant Munkwase
collection DOAJ
description This study assessed the effect of efavirenz mid-dose plasma concentrations on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among 49 HIV infected women coadministering ethinylestradiol/levonorgestrel, including 34 HIV positive women on Highly Active Antiretroviral Therapy (HAART) and 15 HAART naïve HIV infected women, purposively selected from Mulago Hospital, Uganda. A blood sample was collected once between days 20 and 22 of each woman’s menstrual cycle for measuring endogenous progesterone and efavirenz concentrations by electrochemiluminescence technology and High Performance Liquid Chromatography (HPLC), respectively. Descriptive statistical analysis and correlation and logistic regression analysis were done using SPSS v.21 and R3.1. Efavirenz showed a weak positive linear relationship with endogenous progesterone at efavirenz concentrations below 12 μg/ml. Based on serum endogenous progesterone, the observed hormonal contraceptives failure rate (24.5%) was higher than expected (maximum 8%). A higher proportion of HIV positive women on efavirenz based HAART (26.5%) was at risk of contraceptive failure than their HIV infected HAART naïve counterparts (20%) though it was not statistically significant (p=0.63). Efavirenz mid-dose plasma concentrations seem to have no significant effect on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among HIV infected Ugandan women coadministering ethinylestradiol/levonorgestrel oral pills.
format Article
id doaj-art-9e941698b9e84913946ef0362b6a6c85
institution Kabale University
issn 2090-1240
2090-1259
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series AIDS Research and Treatment
spelling doaj-art-9e941698b9e84913946ef0362b6a6c852025-02-03T05:51:54ZengWileyAIDS Research and Treatment2090-12402090-12592017-01-01201710.1155/2017/65317096531709Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/LevonorgestrelGrant Munkwase0Kuteesa R. Bisaso1Othman Kakaire2Sarah Nanzigu3Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, UgandaDepartment of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, UgandaDepartment of Obstetrics and Gynaecology, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, UgandaDepartment of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, P.O. Box 7062, Kampala, UgandaThis study assessed the effect of efavirenz mid-dose plasma concentrations on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among 49 HIV infected women coadministering ethinylestradiol/levonorgestrel, including 34 HIV positive women on Highly Active Antiretroviral Therapy (HAART) and 15 HAART naïve HIV infected women, purposively selected from Mulago Hospital, Uganda. A blood sample was collected once between days 20 and 22 of each woman’s menstrual cycle for measuring endogenous progesterone and efavirenz concentrations by electrochemiluminescence technology and High Performance Liquid Chromatography (HPLC), respectively. Descriptive statistical analysis and correlation and logistic regression analysis were done using SPSS v.21 and R3.1. Efavirenz showed a weak positive linear relationship with endogenous progesterone at efavirenz concentrations below 12 μg/ml. Based on serum endogenous progesterone, the observed hormonal contraceptives failure rate (24.5%) was higher than expected (maximum 8%). A higher proportion of HIV positive women on efavirenz based HAART (26.5%) was at risk of contraceptive failure than their HIV infected HAART naïve counterparts (20%) though it was not statistically significant (p=0.63). Efavirenz mid-dose plasma concentrations seem to have no significant effect on mid-luteal endogenous progesterone concentrations and contraceptive outcomes among HIV infected Ugandan women coadministering ethinylestradiol/levonorgestrel oral pills.http://dx.doi.org/10.1155/2017/6531709
spellingShingle Grant Munkwase
Kuteesa R. Bisaso
Othman Kakaire
Sarah Nanzigu
Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
AIDS Research and Treatment
title Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
title_full Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
title_fullStr Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
title_full_unstemmed Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
title_short Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
title_sort effect of efavirenz on endogenous progesterone concentrations and contraceptive outcomes among ugandan hiv infected women coadministering ethinylestradiol levonorgestrel
url http://dx.doi.org/10.1155/2017/6531709
work_keys_str_mv AT grantmunkwase effectofefavirenzonendogenousprogesteroneconcentrationsandcontraceptiveoutcomesamongugandanhivinfectedwomencoadministeringethinylestradiollevonorgestrel
AT kuteesarbisaso effectofefavirenzonendogenousprogesteroneconcentrationsandcontraceptiveoutcomesamongugandanhivinfectedwomencoadministeringethinylestradiollevonorgestrel
AT othmankakaire effectofefavirenzonendogenousprogesteroneconcentrationsandcontraceptiveoutcomesamongugandanhivinfectedwomencoadministeringethinylestradiollevonorgestrel
AT sarahnanzigu effectofefavirenzonendogenousprogesteroneconcentrationsandcontraceptiveoutcomesamongugandanhivinfectedwomencoadministeringethinylestradiollevonorgestrel